Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Regional airports like Palm Springs International Airlines are trying to expand international offerings after traffic ...

The percentage of wildfire-associated emergency department encounters increased with onset of the Los Angeles County (LAC) ...

On Thursday, former Vice President Kamala Harris toured the Palisades fire zone with Supervisor Lindsay Horvath, while EPA ...

Beaver Stadium looks drastically different, as the West side's press box and upper seating deck have been removed.

The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...

Kura and Kyowa used the announcement to confirm that they are on track to file a new drug approval application with the FDA ...

Jasper’s Downtown Revitalization Phase II Project is moving forward despite recent setbacks caused by last month’s ice storm, according to city officials. Construction teams are working to compensate ...

And with a growing number of companies in the GLP-1 space, investors may be losing interest in the stock. Could Viking's ...

Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...